Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome (Q33854586)

29 July 2017

Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome (English)

1 reference

29 July 2017

Forsyth LM

1

1 reference

29 July 2017

Preuss HG

2

1 reference

29 July 2017

MacDowell AL

3

1 reference

29 July 2017

Chiazze L Jr

4

1 reference

29 July 2017

Birkmayer GD

5

1 reference

29 July 2017

Bellanti JA

6

1 reference

29 July 2017

1 February 1999

1 reference

Annals of Allergy, Asthma & Immunology

29 July 2017

1 reference

29 July 2017

82

1 reference

29 July 2017

2

1 reference

29 July 2017

185-191

1 reference

History of chronic fatigue syndrome

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Prevalence of fatigue and chronic fatigue syndrome in a primary care practice

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

CHRONIC FATIGUE SYNDROME: An Update

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Chronic fatigue syndrome: a working case definition.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Review of laboratory findings for patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Immunologic abnormalities in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Immune responses associated with chronic fatigue syndrome: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Serologic and Virologic Epidemiology of Epstein-Barr Virus: Relevance to Chronic Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

alpha-Interferon treatment of patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Interferon-alpha therapy for patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Allergy and the chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962595-1

7 January 2021

10.1016/S1081-1206(10)62595-1

Identifiers

DOI

1 reference

29 July 2017

1 reference